Download
slide1 n.
Skip this Video
Loading SlideShow in 5 Seconds..
Voso et al, Supplementary Figure 1 PowerPoint Presentation
Download Presentation
Voso et al, Supplementary Figure 1

Voso et al, Supplementary Figure 1

92 Vues Download Presentation
Télécharger la présentation

Voso et al, Supplementary Figure 1

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Oligonucleotide sequences and PCR conditions used for sequencing Voso et al, Supplementary Figure 1

  2. Exemplary sequencing reactions for all genes studied Voso et al, Supplementary Figure 2

  3. Time to Leukemic evolution SRSF2-mutated SRSF2-wild type Probability (%) p=0.04 Months from MPN diagnosis Voso et al, Supplementary Figure 3

  4. Characteristics of patients with leukemias secondary to chronic myeloproliferative neoplasms *Of 5 patients with a complex karyotype, 2 had 11q23 abnormalities and 3 had a chromosome 5 and/or 7 deletion Voso et al, Supplementary Table 1

  5. Prevalence of mutations in patients with leukemias Secondary to chronic myeloproliferative neoplasms * One patient with a previous PV had synchronous IDH2 R140Q and DNMT3A R882H mutations ** p=0.025 Voso et al, Supplementary Table 2